Radiotherapy to augment pembrolizumab responses and outcomes in metastatic non-small cell lung cancer: Pooled analysis of two randomized trials.

James Welsh,Dawei Chen,Paul Baas,Joe Y. Chang,Vivek Verma,Nathan Comeaux,Ferdinandos Skoulidis,Steven H. Lin,John V. Heymach,Willemijn S. M. E. Theelen

Radiotherapy to augment pembrolizumab responses and outcomes in metastatic non-small cell lung cancer: Pooled analysis of two randomized trials.

2020

James Welsh
Dawei Chen
Paul Baas
Joe Y. Chang
Vivek Verma
Nathan Comeaux
Ferdinandos Skoulidis
Steven H. Lin
John V. Heymach
Willemijn S. M. E. Theelen

9548Background: In metastatic non-small cell lung cancer (mNSCLC), the clinical trials NCT02492568 and NCT02444741 are the only known randomized comparisons of pembrolizumab alone versus pembrolizu...

Keywords:

Internal medicine
Lung cancer
Oncology
pooled analysis
non small cell
Augment
Pembrolizumab
Pathology
Randomized controlled trial
Medicine
Radiation therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations